Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06608810
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-09-18
Brief Title:
The Application of Pectoral Nerve IIPECS IIblock in Breast Fibroadenoma Resection Surgery
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Comparison of Efficacy in Pectoral Nerve Block Type II Thoracic Paravertebral Block and General Anesthesia Alone for Excision of Breast Fibroma a Prospective Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PECS II
Brief Summary:
Patients were randomly assigned to the GA group PECS II group or TPVB group using a computer-generated random number table Group assignments were kept in a sealed envelope which was opened only after induction of general anesthesia on the day of surgery This study was a double-blind trial ensuring that neither the patients nor the investigators were aware of the analgesic method used The same anesthesiologist was responsible for PECS II block or TPVB while different anesthesiologists were responsible for anesthesia implementation and postoperative follow-up
Detailed Description:
Written informed consent was obtained from all participants90 female patients aged 18 to 65 with ASA I-II status were selected at Baogang Hospital Inner Mongolia who had been diagnosed with breast fibroadenomas Exclusion criteria included pre-existing infection at the site of block coagulation disorders morbid obesity body mass index ampgt 40 kgm² allergy to local anesthetics impaired lung function significant cardiac disease renal dysfunction pre-existing neurological disorders and psychiatric conditions
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None